2023-03-20 08:55:16 ET
- India Globalization Capital ( NYSE: IGC ) has announced it will begin operating under the new name IGC Pharma, effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma’s strategic focus and vision for the future.
- The common stock will continue to be quoted on the NYSE under the same symbol IGC and its CUSIP and EIN numbers will remain the same.
- "The name change to IGC Pharma acknowledges the Co.’s identity as a developer of drug assets for treating diseases, including, but not limited to, Alzheimer’s disease." said Ram Mukunda, CEO of IGC.
For further details see:
India Globalization Capital announces rebranding to IGC Pharma